Irreversible, Tight-Binding Inhibition of Adenosine Deaminase by Coformycins: Inhibitor Structural Features That Contribute to the Mode of Enzyme Inhibition-Reference-Cited by-同舟云学术

Irreversible, Tight-Binding Inhibition of Adenosine Deaminase by Coformycins: Inhibitor Structural Features That Contribute to the Mode of Enzyme Inhibition

Published:1997-07 Issue:7-9 Volume:16 Page:1053-1057
ISSN:0732-8311
Container-title:Nucleosides and Nucleotides
language:en
Short-container-title:Nucleosides and Nucleotides

Author:

Hong Mikyung,Hosmane Ramachandra S.

Publisher

Informa UK Limited

Subject

Genetics,Biochemistry

Reference25 articles.

1. Structure of coformycin, an unusual nucleoside of microbial origin

2. Synthesis of coformycin

3. Total synthesis of (4R)- and (4S)-5,6-dihydro-1-.beta.-D-ribofuranosyl-4H-pyrazolo[3,4-d][1,3]diazepin-4-ol and (8R)- and (8S)-7,8-dihydro-3-.beta.-D-ribofuranosyl-6H-v-triazolo[4,5-d][1,3]diazepin-8-ol: two heterocyclic analogs of the nucleoside antibiotic coformycin

4. A novel adenosine and ara-a deaminase inhibitor, (R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5 -d] [1,3]diazepin-8-ol

5. A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on bioactive fused heterocycles as purine-utilizing enzymes inhibitors;Medicinal Chemistry Research;2014-11-16

2. Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system;Chemical Communications;2012

3. Chemistry of Inflammation and DNA Damage: Biological Impact of Reactive Nitrogen Species;The Chemical Biology of DNA Damage;2010-10-11

4. ChemInform Abstract: Irreversible, Tight-Binding Inhibition of Adenosine Deaminase by Coformycins: Inhibitor Structural Features That Contribute to the Mode of Enzyme Inhibition.;ChemInform;2010-06-23

5. Chapter 2: Ring-Expanded (‘Fat‘) Purines and their Nucleoside/Nucleotide Analogues as Broad-Spectrum Therapeutics;Progress in Heterocyclic Chemistry;2009